HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.

AuthorsYu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Victoria C Yan, Yasaman Barekatain, Sunada Khadka, Jeffrey J Ackroyd, Dimitra K Georgiou, Cong-Dat Pham, Kenisha Arthur, David Maxwell, Zhenghong Peng, Paul G Leonard, Barbara Czako, Federica Pisaneschi, Pijus Mandal, Yuting Sun, Rafal Zielinski, Susana Castro Pando, Xiaobo Wang, Theresa Tran, Quanyu Xu, Qi Wu, Yongying Jiang, Zhijun Kang, John M Asara, Waldemar Priebe, William Bornmann, Joseph R Marszalek, Ronald A DePinho, Florian L Muller
JournalNature metabolism (Nat Metab) Vol. 3 Issue 1 Pg. 122 (Jan 2021) ISSN: 2522-5812 [Electronic] Germany
PMID33340032 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: